These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9811967)

  • 1. Human collagen II peptide 256-271 preferentially binds to HLA-DR molecules associated with susceptibility to rheumatoid arthritis.
    Diab BY; Lambert NC; L'Faqihi FE; Loubet-Lescoulié P; de Préval C; Coppin H
    Immunogenetics; 1999 Jan; 49(1):36-44. PubMed ID: 9811967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
    Rosloniec EF; Whittington KB; Zaller DM; Kang AH
    J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of HLA class II molecules divergently associated with Goodpasture's disease.
    Phelps RG; Jones V; Turner AN; Rees AJ
    Int Immunol; 2000 Aug; 12(8):1135-43. PubMed ID: 10917888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen.
    Rosloniec EF; Ivey RA; Whittington KB; Kang AH; Park HW
    J Immunol; 2006 Sep; 177(6):3884-92. PubMed ID: 16951351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.
    Sakurai Y; Brand DD; Tang B; Rosloniec EF; Stuart JM; Kang AH; Myers LK
    Arthritis Res Ther; 2006; 8(5):R150. PubMed ID: 16982003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice.
    Andersson EC; Hansen BE; Jacobsen H; Madsen LS; Andersen CB; Engberg J; Rothbard JB; McDevitt GS; Malmström V; Holmdahl R; Svejgaard A; Fugger L
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7574-9. PubMed ID: 9636191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
    Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH
    Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity versus tolerance: analysis using transgenic mice.
    Taneja V; David CS
    Hum Immunol; 2000 Dec; 61(12):1383-9. PubMed ID: 11163096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles.
    Patil NS; Pashine A; Belmares MP; Liu W; Kaneshiro B; Rabinowitz J; McConnell H; Mellins ED
    J Immunol; 2001 Dec; 167(12):7157-68. PubMed ID: 11739539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DQ-binding peptide motifs. 1. Comparative binding analysis of type II collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplotypes.
    Matsushita S; Nishi T; Oiso M; Yamaoka K; Yone K; Kanai T; Nishimura Y
    Int Immunol; 1996 May; 8(5):757-64. PubMed ID: 8671664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen.
    Rosloniec EF; Brand DD; Myers LK; Esaki Y; Whittington KB; Zaller DM; Woods A; Stuart JM; Kang AH
    J Immunol; 1998 Mar; 160(6):2573-8. PubMed ID: 9510154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mouse models of rheumatoid arthritis.
    Holmdahl R; Andersson EC; Andersen CB; Svejgaard A; Fugger L
    Immunol Rev; 1999 Jun; 169():161-73. PubMed ID: 10450516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell immunity to type II collagen in the biobreeding rat: the identification and characterization of RT1u-restricted T cell epitopes on alpha 1(II).
    Cremer MA; Ye XJ; Myers LK; Brand DD; Rosloniec EF; Kang AH
    J Immunol; 2004 Aug; 173(3):1795-801. PubMed ID: 15265910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human HLA-DR beta gene hypervariable region homology in the biobreeding BB rat: selection of the diabetic-resistant subline as a rheumatoid arthritis research tool to characterize the immunopathologic response to human type II collagen.
    Watson WC; Thompson JP; Terato K; Cremer MA; Kang AH
    J Exp Med; 1990 Nov; 172(5):1331-9. PubMed ID: 1700052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
    Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
    J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules.
    Fridkis-Hareli M; Neveu JM; Robinson RA; Lane WS; Gauthier L; Wucherpfennig KW; Sela M; Strominger JL
    J Immunol; 1999 Apr; 162(8):4697-704. PubMed ID: 10202010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition.
    Zanelli E; Krco CJ; David CS
    J Immunol; 1997 Apr; 158(7):3545-51. PubMed ID: 9120317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules.
    Kjellén P; Brunsberg U; Broddefalk J; Hansen B; Vestberg M; Ivarsson I; Engström A; Svejgaard A; Kihlberg J; Fugger L; Holmdahl R
    Eur J Immunol; 1998 Feb; 28(2):755-67. PubMed ID: 9521085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis.
    Di Sante G; Tolusso B; Fedele AL; Gremese E; Alivernini S; Nicolò C; Ria F; Ferraccioli G
    EBioMedicine; 2015 Dec; 2(12):2037-45. PubMed ID: 26844284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.